School of the Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Department of Gynecological Oncology, Cancer Hospital of University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, 310022, People's Republic of China.
Mol Brain. 2021 Jul 19;14(1):119. doi: 10.1186/s13041-021-00831-5.
Epigenetic abnormalities play a crucial role in many tumors, including glioma. RNA methylation occurs as an epigenetic modification similar to DNA methylation and histone modification. mA methylation is the most common and most intensively studied RNA methylation, which can be found throughout the RNA life cycle and exert biological functions by affecting RNA metabolism. The mA modification is primarily associated with three types of protease, which are encoded by the writer, eraser and reader genes, respectively. It has been shown that the mA methylation has close connections with the occurrence and development of many tumors, including glioma. In this study, the concept and the research progress of mA methylation are reviewed, especially the role of mA methylation in glioma. Moreover, we will discuss how glioma is paving the way to the development of new therapeutic options based on the inhibition of mA deposition.
表观遗传异常在许多肿瘤中起着关键作用,包括神经胶质瘤。RNA 甲基化作为一种表观遗传修饰,类似于 DNA 甲基化和组蛋白修饰。m6A 甲基化是最常见和研究最深入的 RNA 甲基化,它可以在整个 RNA 生命周期中发生,并通过影响 RNA 代谢来发挥生物学功能。m6A 修饰主要与三种类型的蛋白酶有关,它们分别由作家、橡皮擦和读者基因编码。已经表明,m6A 甲基化与许多肿瘤的发生和发展密切相关,包括神经胶质瘤。在本研究中,综述了 m6A 甲基化的概念和研究进展,特别是 m6A 甲基化在神经胶质瘤中的作用。此外,我们将讨论神经胶质瘤如何为基于 m6A 沉积抑制的新治疗选择的发展铺平道路。